Exosomes – tiny biological nanoparticles which transfer information between cells – offer significant potential in detecting and treating disease, the most comprehensive overview so far of research in the field has concluded.
Areas which could benefit include cancer treatment and regenerative medicine, say Dr Steven Conlan from Swansea University, Dr Mauro Ferrari of Houston Methodist Research Institute in Texas, and Dr Inês Mendes Pinto from the International Iberian Nanotechnology Laboratory in Portugal. Their commissioned paper, Exosomes as Reconfigurable Therapeutic Systems, is published today by Cell Press in Trends in Molecular Medicine.
Exosomes are particles produced by all cells in the body and are from 30-130 nanometres in size – a nanometre is one-billionth of a metre. They act as biological signalling systems, communicating between cells, carrying proteins, lipids, DNA and RNA. They drive biological processes, from modulating gene expression to transmitting information through breast milk.
Though discovered in 1983, the full potential of exosomes is only gradually being revealed. The researchers show that the nanoparticles’ possible medical benefits fall into three broad categories:
- Detecting disease – by acting as disease-specific biomarkers
- Activating immune responses to boost immunity
- Treating diseases – serving as the vehicle for drugs, for example bearing cancer therapies as their payload, to target tumours
One of the most useful properties of exosomes is that they are able to cross barriers such as the plasma membrane of cells, or the blood/brain barrier. This makes them well-suited to delivering therapeutic molecules in a very targeted way.
The potential benefits of exosomes can be seen in the wide range of research projects – cited in the paper – already either completed or under way, in areas such as:
- Improved testing for prostate cancer
- A small-cell lung cancer trial
- Stem cell-derived exosomes strengthening heart muscles
- Regeneration of muscle and tissue
The team caution that there is more to do before research into exosomes translates into new techniques and treatments. Side-effects need to be considered, and a standardised approach to isolating, characterising and storing exosomes will need to be developed.
Researchers will also need to ensure that the properties of exosomes do not end up causing harm: for example they can transfer drug resistance and pacify the immune system.
Nevertheless, the potential is very clear, with the team describing exosomes as “increasingly promising”.
Professor Steve Conlan of Swansea University Medical School, one of the authors of the paper, said:
“Our survey of research into exosomes shows clearly that they offer enormous potential as a basis for detecting and treating disease.
Further studies are necessary to turn this research into clinical outcomes, but researchers and funders should be very encouraged by our findings. Our own research in Swansea is investigating the use of exosomes and exosome-like synthetic nanoparticles in combatting ovarian and endometrial cancer.
Progress in this field depends on partnership. As the authorship of our own paper illustrates, researchers in different countries are increasingly working together in nanohealth. Swansea University has wider links with Houston and Portuguese based researchers in the field.
It’s also important to build partnerships outside academia, in particular with government and companies in this fast-growing sector.”
The Latest on: Exosomes
- Researchers Say Flu Vaccines May Shrink Tumors and Aid in Treating Canceron January 22, 2020 at 5:43 am
The questions of whether the flu shot may be the next step in fighting cancer has been raised as recent experiments in mouse models have shown that injecting an inactivated flu virus into cancer ...
- Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast canceron January 22, 2020 at 1:46 am
Recent studies indicate that exosomes act as vehicles for exchange of genetic cargo between heterogeneous populations of tumor cells, engendering a transmitted drug resistance for cancer development ...
- Exosome Therapy for Stroke Produces Full Recovery in Animal Modelon January 15, 2020 at 11:13 pm
Expanding upon previous work that developed a treatment using a type of extracellular vesicles known as exosomes—small fluid-filled structures that are created by stem cells—investigators at the ...
- Global Stem Cells Group Releases New Product to Meet Growing Demand for Birth Tissue Derived Compoundson January 15, 2020 at 2:25 pm
The product, Cellgenic Flow Exosomes, is 100% natural and is available in a 1 mL vial comprised of 5 billion exosomes per mL and is currently manufactured in Mexico and in Global’s US-based facilities ...
- Sticky situation inside blood vessels can worsen stroke damageon January 15, 2020 at 7:01 am
They have found that after stroke, exosomes -- nanosized biological suitcases packed with an assortment of cargo that cells swap, like proteins and fats -- traveling in the blood get activated and ...
- Exosomes promote remarkable recovery in strokeon January 14, 2020 at 6:44 am
Exosomes are considered to be powerful mediators of long-distance cell-to-cell communication that can change the behavior of tumor and neighboring cells. The results of the study echo findings from ...
- Poster: Exosomes – Contents by Cell Type and Processon January 9, 2020 at 5:10 am
When exosomes were first discovered they were thought to be nothing more than cellular waste containers, but it is now thought that the integral membrane proteins, soluble proteins, and nucleic acid ...
- New Gene Therapy Uses Exosomes to Reverse Diseaseon December 22, 2019 at 10:20 pm
Researchers at Ohio State University have developed a new gene therapy that makes use of exosomes, fluid sacs released in cells, to carry therapeutic tools to targeted sites around the body. A process ...
- Codiak Presents First Preclinical Data for exoASO, Engineered Exosomes Designed to Reprogram Tumor-Associated Macrophageson November 18, 2019 at 1:10 pm
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Codiak BioSciences, Inc., a company at the forefront of advancing engineered exosomes as a new class of biologic medicines, today announced the first preclinical ...
- The exosomes market is expected to register a CAGR of nearly 18.0% during the forecast period, 2019on November 10, 2019 at 4:00 pm
The exosomes market is expected to register a CAGR of nearly 18.0% during the forecast period, 2019-2024. Read the full report: https://www.reportlinker.com/p05826220 ...
via Google News and Bing News